Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Change in Inventory (2018 - 2025)

Ultragenyx Pharmaceutical has reported Change in Inventory over the past 8 years, most recently at -$150000.0 for Q4 2025.

  • Quarterly Change in Inventory fell 106.67% to -$150000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2025, down 45.45% year-over-year, with the annual reading at $6.0 million for FY2025, 45.45% down from the prior year.
  • Change in Inventory was -$150000.0 for Q4 2025 at Ultragenyx Pharmaceutical, down from $5.6 million in the prior quarter.
  • Over five years, Change in Inventory peaked at $5.6 million in Q3 2025 and troughed at -$474000.0 in Q1 2021.
  • The 5-year median for Change in Inventory is $1.8 million (2023), against an average of $1.8 million.
  • Year-over-year, Change in Inventory plummeted 218.12% in 2021 and then skyrocketed 1782.98% in 2022.
  • A 5-year view of Change in Inventory shows it stood at $990000.0 in 2021, then soared by 324.75% to $4.2 million in 2022, then crashed by 51.82% to $2.0 million in 2023, then rose by 11.01% to $2.2 million in 2024, then crashed by 106.67% to -$150000.0 in 2025.
  • Per Business Quant, the three most recent readings for RARE's Change in Inventory are -$150000.0 (Q4 2025), $5.6 million (Q3 2025), and -$208000.0 (Q2 2025).